Placebo: Misunderstandings and prejudices;Placebo: Missverständnisse und vorurteile

Deutsches Arzteblatt

Volumn 106, Issue 46, 2009, Pages 751-755

  Breidert, Matthias ^a   Hofbauer, Karl ^a  

^a Kliniken im Naturpark Altmuhltal   (Germany)

Author keywords

Complementary medicine; Drug research; Drug safety; Medical prescriptions; Treatment study

Indexed keywords

PLACEBO;

CLINICAL TRIAL; DRUG MECHANISM; HUMAN; PERSONALITY; PHYSICIAN ATTITUDE; PLACEBO EFFECT; REVIEW; SIMULATION; SOCIAL PSYCHOLOGY; THERAPY EFFECT;

CLINICAL TRIALS AS TOPIC; CONDITIONING (PSYCHOLOGY); PATIENT SATISFACTION; PLACEBO EFFECT; PREJUDICE; SET (PSYCHOLOGY);

EID: 76149125776     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2009.0751     Document Type: Review

References (35)

1. Shang A, Huwiler-Müntener K, Nartey L, et al. : Are the clinical effects of homeopathy placebo effects? Comparative study of placebo-controlled trials of homeopathy and allopathy. Lancet 2005; 366: 726-32.
2. Furmark T, Appel L, Henningsson S, et al. : A link between serotoninrelated gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci 2008; 28: 13066-74.
3. McQuay HJ, Moore RA: Placebo. Postgrad Med J 2005; 81: 155-60.
4. Schönbächler G: Placebo. Schweiz Med Forum 2007; 7: 205-10.
5. Enck P, Benedetti F, Schedlowski M: New insights into the placebo and nocebo responses. Neuron 2008; 59: 195-206.
6. Oeltjenbruns J, Schäfer M: Klinische Bedeutung des Placeboeffektes. Anaesthesist 2008; 57: 447-63.
7. Quitkin FM: Placebos, drug effects, and study design: a clinician's guide. Am J Psychiatry 1999, 156: 829-36.
8. Edward SJL, Stevens AJ, Braunholtz DA, Lilford RJ, Swift T: The ethics of placebo-controlled trials: a comparison of inert and active placebo controls. World J Surg 2005; 29: 610-14.
9. Barsky AJ, Saintford R, Rogers MP, Borus JF: Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002; 287: 622-7.
10. Kennedy WP: The nocebo reaction. Med World 1961; 95: 203-5.
11. Benedetti F, Lanotte M, Lopiano L, Colloca L: When words are painful: unravelling the mechanisms of the nocebo effect. Neuroscience 2007; 147: 260-71.
12. Beecher HK: The powerful placebo. JAMA 1955; 159: 1602-6.
13. Kienle GS, Kiene H: The powerful placebo effect: fact or fiction? J Clin Epidemiol 1997; 50: 1308-11.
14. Geers AL, Helfer SG, Kosbab K, Weiland PE, Landry SJ: Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response. J Psychosomat Res 2005; 58: 121-7.
15. Hrobjartsson A , Gotzsche PC: Is the placebo powerless? N Engl J Med 2001; 344: 1594-602.
16. Hrobjartsson A , Gotzsche PC: Is the placebo powerless? Uptodate of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med 2004; 256: 91-100.
17. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M: The placebo effect and its determinants in osteoarthritis-meta-analysis of randomised controlled trials. Ann Rheum Dis 2008; 67: 1716-23.
18. De Craen AJM, Roos PJ, de Vries AL, Kleijnen J: Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness. BMJ 1996; 313: 1624-6.
19. Waber RL, Shiv B, Carmon Z, Ariely D: Commercial features of placebo and therapeutic efficacy. JAMA 2008; 299: 1016-7.
20. Plassmann H, O'Doherty JO, Shiv B, Rangel A: Marketing actions can modulate neural representations of experienced pleasantness. PNAS 2008; 105: 1050-4.
21. Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J: Influence of context effects on health outcomes: a systematic review. Lancet 2001; 357: 757-62.
22. Kaptchuk TJ, Kelley JM, Conboy LA, et al.: Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008; 336: 999-1003.
23. Graz B, Wietlisbach V, Porchet F, Vader JP: Prognosis or .,curabo effect?": physician prediction and patient outcome of surgery for low back pain and sciatica. Spine 2005; 30:1448-52.
24. Zwingmann C, Wirtz M: Regression zur Mitte. Rehabilitation 2005; 44: 244-51.
25. Benedetti F, Amanzi M,Vighetti S, Asteggiano G: The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 2006; 26: 12014-22.
26. e1. Koshi EB, Short CA: Placebo theory and its implications for research and clinical practice: a review of the recent literature. Pain Practice 2007; 7: 4-20.
27. e2. Herr HW: Franklin, Lavoisier, and Mesmer: origin of the controlled clinical trial. Urologic Oncology 2005; 23: 346-51.
28. e3. Asmar R, Safar M, Queneau P: Evaluation of the placebo effect and reproducibility of blood pressure measurement in hyperten - sion. AJH 2001; 14: 546-52.
29. e4. Stockhorst U: Classical conditioning of endocrine effects. Curr Opin Psychiatry 2005; 18: 181-7.
30. e5. Fedele L, Marchini M, Acaia B, Garagiola U, Tiengo M: Dynamics and significance of placebo response in primary dysmenorrhea. Pain 1989; 36: 43-7.
31. e6. Park LC, Covi U: Nonblind placebo trial. Arch Gen Psychiatry 1965; 12: 336-45.
32. e7. Bland JM, Altman DG: Regression towards the mean. BMJ 1994; 308: 1499.
33. e8. Lichtenberg P, Heresco-Levy U, Nitzan U: The ethics of placebo in clinical practice. J Med Ethics 2004; 30: 551-4.
34. e9. Tilburt JC, Emanuel EJ, Kaptchuk TJ, Curlin FA, Miller FG: Prescrib ing "placebo treatments": results of national survey of US internists and rheumatologists. BMJ 2008; 337: a1938.
35. e10. Zernikow B, Hechler, T: Pain therapy in children and adolescents [Schmerztherapie bei Kindern und Jugendlichen]. Dtsch Arztebl Int 2008; 105(28-29): 511-22.